Literature DB >> 3098971

Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes.

K Kaur, K Emmett, P P McCann, A Sjoerdsma, B Ullman.   

Abstract

Alpha-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, has been demonstrated to be an effective agent against a variety of parasitic protozoa but not against Leishmania spp. In this report, we show that Leishmania donovani promastigotes in continuous culture are sensitive to the growth inhibitory and cytotoxic effects of DFMO. Incubation of the promastigotes with DFMO obliterates intracellular putrescine pools and depletes spermidine concentrations, which correlates with the onset of growth inhibition. The effects of DFMO on the growth and the intracellular polyamine pools can be reversed completely by the addition of 10 microM putrescine to the culture medium. These results suggest that the treatment of leishmaniasis may be amenable to chemotherapeutic manipulation by DFMO.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098971     DOI: 10.1111/j.1550-7408.1986.tb05654.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  19 in total

1.  Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.

Authors:  Sigrid C Roberts; Yuqui Jiang; Judith Gasteier; Benjamin Frydman; Laurence J Marton; Olle Heby; Buddy Ullman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane.

Authors:  Veronica T Dufe; Daniel Ingner; Olle Heby; Alex R Khomutov; Lo Persson; Salam Al-Karadaghi
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

3.  Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads.

Authors:  Timothy J Hubin; Ashlie N Walker; Dustin J Davilla; TaRynn N Carder Freeman; Brittany M Epley; Travis R Hasley; Prince N A Amoyaw; Surendra Jain; Stephen J Archibald; Timothy J Prior; Jeanette A Krause; Allen G Oliver; Babu L Tekwani; M Omar F Khan
Journal:  Polyhedron       Date:  2019-02-23       Impact factor: 3.052

4.  Alpha-difluoromethylornithine-resistant cell lines obtained after one-step selection of Leishmania mexicana promastigote cultures.

Authors:  C P Sánchez; J Mucci; N S González; A Ochoa; M M Zakin; I D Algranati
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

5.  Spermidine synthase is required for virulence of Leishmania donovani.

Authors:  Caslin Gilroy; Tamara Olenyik; Sigrid C Roberts; Buddy Ullman
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

6.  Polyamine content and drug sensitivities of different clonal lines of Leishmania infantum promastigotes.

Authors:  L Carrera; R Balaña-Fouce; J M Alunda
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

7.  Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections.

Authors:  Edward L D'Antonio; Buddy Ullman; Sigrid C Roberts; Upasna Gaur Dixit; Mary E Wilson; Yang Hai; David W Christianson
Journal:  Arch Biochem Biophys       Date:  2013-04-09       Impact factor: 4.013

8.  Suppression of Leishmania donovani by oral administration of a bis(benzyl)polyamine analog.

Authors:  R J Baumann; P P McCann; A J Bitonti
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

9.  Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog.

Authors:  R J Baumann; W L Hanson; P P McCann; A Sjoerdsma; A J Bitonti
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Putrescine uptake regulation in response to alpha-difluoromethylornithine treatment in Leishmania infantum promastigotes.

Authors:  R Balaña Fouce; M I Escribano; J M Alunda
Journal:  Mol Cell Biochem       Date:  1991-10-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.